Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study

Introduction: The typical spatial pattern of amyloid-β (Aβ) in diagnosed Alzheimer’s disease (AD) is that of a symmetrical hemispheric distribution. However, Aβ may be asymmetrically distributed in early stages of AD. Aβ distribution on PET has previously been explored in MCI and AD, but it has yet...

Full description

Bibliographic Details
Main Authors: Pernille L. Kjeldsen, Peter Parbo, Kim V. Hansen, Joel F.A. Aanerud, Rola Ismail, Peter H. Nissen, Rikke B. Dalby, Malene F. Damholdt, Per Borghammer, David J. Brooks
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Aging Brain
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589958922000202
_version_ 1811197441182007296
author Pernille L. Kjeldsen
Peter Parbo
Kim V. Hansen
Joel F.A. Aanerud
Rola Ismail
Peter H. Nissen
Rikke B. Dalby
Malene F. Damholdt
Per Borghammer
David J. Brooks
author_facet Pernille L. Kjeldsen
Peter Parbo
Kim V. Hansen
Joel F.A. Aanerud
Rola Ismail
Peter H. Nissen
Rikke B. Dalby
Malene F. Damholdt
Per Borghammer
David J. Brooks
author_sort Pernille L. Kjeldsen
collection DOAJ
description Introduction: The typical spatial pattern of amyloid-β (Aβ) in diagnosed Alzheimer’s disease (AD) is that of a symmetrical hemispheric distribution. However, Aβ may be asymmetrically distributed in early stages of AD. Aβ distribution on PET has previously been explored in MCI and AD, but it has yet to be directly investigated in preclinical AD (pAD). We examined how Aβ was distributed in individuals with pAD and MCI using 11C-Pittsburgh Compound B (PiB) PET. Methods: In this PET study, 79 subjects were retrospectively enrolled, including 34 controls, 24 pAD, and 21 MCI. All subjects underwent APOE genotyping, 11C-PiB PET, MRI, and cognitive testing. We explored differences in Aβ load, Aβ lateralisation, and Aβ distribution, as well as associations between Aβ distribution and cognition. Results: The Aβ asymmetry index (AI) differed between groups, with pAD having the highest Aβ AI as compared to both controls and MCI. There was no clear Aβ lateralisation in pAD, but there was a non-significant trend towards Aβ being more left-lateralised in MCI. There were no correlations between the cognitive scores and Aβ AI or Aβ lateralisation in pAD or MCI. Conclusion: The distribution of Aβ is most asymmetrical in pAD, as Aβ first starts accumulating, and it then becomes less asymmetrical in MCI, when Aβ has spread further, suggesting that more pronounced asymmetrical Aβ distribution may be a distinguishing factor in pAD. Longitudinal studies examining the distribution of Aβ across the AD continuum are needed.
first_indexed 2024-04-12T01:13:42Z
format Article
id doaj.art-d4f233cd10d145528054e34755010fb9
institution Directory Open Access Journal
issn 2589-9589
language English
last_indexed 2024-04-12T01:13:42Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Aging Brain
spelling doaj.art-d4f233cd10d145528054e34755010fb92022-12-22T03:54:01ZengElsevierAging Brain2589-95892022-01-012100048Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET studyPernille L. Kjeldsen0Peter Parbo1Kim V. Hansen2Joel F.A. Aanerud3Rola Ismail4Peter H. Nissen5Rikke B. Dalby6Malene F. Damholdt7Per Borghammer8David J. Brooks9Dept. of Clinical Medicine, Aarhus University, Denmark; Dept. of Nuclear Medicine and PET, Aarhus University Hospital, DenmarkDept. of Clinical Medicine, Aarhus University, Denmark; Dept. of Nuclear Medicine, Odense University Hospital, DenmarkDept. of Nuclear Medicine and PET, Aarhus University Hospital, DenmarkDept. of Nuclear Medicine and PET, Aarhus University Hospital, DenmarkDept. of Nuclear Medicine, Vejle, Lillebælt Hospital, DenmarkDept. of Clinical Medicine, Aarhus University, Denmark; Dept. of Clinical Biochemistry, Aarhus University Hospital, DenmarkDept. of Clinical Medicine, Aarhus University, Denmark; Dept. of Radiology, Section for Neuroradiology, Aarhus University Hospital, Denmark; Centre for Functionally Integrative Neuroscience, Aarhus University, DenmarkDept. of Clinical Medicine, Aarhus University, Denmark; Dept. of Psychology, Aarhus University, DenmarkDept. of Clinical Medicine, Aarhus University, Denmark; Dept. of Nuclear Medicine and PET, Aarhus University Hospital, DenmarkDept. of Clinical Medicine, Aarhus University, Denmark; Dept. of Nuclear Medicine and PET, Aarhus University Hospital, Denmark; Translational and Clinical Research Institute, Newcastle University, United KingdomIntroduction: The typical spatial pattern of amyloid-β (Aβ) in diagnosed Alzheimer’s disease (AD) is that of a symmetrical hemispheric distribution. However, Aβ may be asymmetrically distributed in early stages of AD. Aβ distribution on PET has previously been explored in MCI and AD, but it has yet to be directly investigated in preclinical AD (pAD). We examined how Aβ was distributed in individuals with pAD and MCI using 11C-Pittsburgh Compound B (PiB) PET. Methods: In this PET study, 79 subjects were retrospectively enrolled, including 34 controls, 24 pAD, and 21 MCI. All subjects underwent APOE genotyping, 11C-PiB PET, MRI, and cognitive testing. We explored differences in Aβ load, Aβ lateralisation, and Aβ distribution, as well as associations between Aβ distribution and cognition. Results: The Aβ asymmetry index (AI) differed between groups, with pAD having the highest Aβ AI as compared to both controls and MCI. There was no clear Aβ lateralisation in pAD, but there was a non-significant trend towards Aβ being more left-lateralised in MCI. There were no correlations between the cognitive scores and Aβ AI or Aβ lateralisation in pAD or MCI. Conclusion: The distribution of Aβ is most asymmetrical in pAD, as Aβ first starts accumulating, and it then becomes less asymmetrical in MCI, when Aβ has spread further, suggesting that more pronounced asymmetrical Aβ distribution may be a distinguishing factor in pAD. Longitudinal studies examining the distribution of Aβ across the AD continuum are needed.http://www.sciencedirect.com/science/article/pii/S2589958922000202Preclinical Alzheimer’s diseasePositron emission tomographyAmyloid depositionAsymmetry
spellingShingle Pernille L. Kjeldsen
Peter Parbo
Kim V. Hansen
Joel F.A. Aanerud
Rola Ismail
Peter H. Nissen
Rikke B. Dalby
Malene F. Damholdt
Per Borghammer
David J. Brooks
Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study
Aging Brain
Preclinical Alzheimer’s disease
Positron emission tomography
Amyloid deposition
Asymmetry
title Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study
title_full Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study
title_fullStr Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study
title_full_unstemmed Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study
title_short Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study
title_sort asymmetric amyloid deposition in preclinical alzheimer s disease a pet study
topic Preclinical Alzheimer’s disease
Positron emission tomography
Amyloid deposition
Asymmetry
url http://www.sciencedirect.com/science/article/pii/S2589958922000202
work_keys_str_mv AT pernillelkjeldsen asymmetricamyloiddepositioninpreclinicalalzheimersdiseaseapetstudy
AT peterparbo asymmetricamyloiddepositioninpreclinicalalzheimersdiseaseapetstudy
AT kimvhansen asymmetricamyloiddepositioninpreclinicalalzheimersdiseaseapetstudy
AT joelfaaanerud asymmetricamyloiddepositioninpreclinicalalzheimersdiseaseapetstudy
AT rolaismail asymmetricamyloiddepositioninpreclinicalalzheimersdiseaseapetstudy
AT peterhnissen asymmetricamyloiddepositioninpreclinicalalzheimersdiseaseapetstudy
AT rikkebdalby asymmetricamyloiddepositioninpreclinicalalzheimersdiseaseapetstudy
AT malenefdamholdt asymmetricamyloiddepositioninpreclinicalalzheimersdiseaseapetstudy
AT perborghammer asymmetricamyloiddepositioninpreclinicalalzheimersdiseaseapetstudy
AT davidjbrooks asymmetricamyloiddepositioninpreclinicalalzheimersdiseaseapetstudy